Urinary Proteomics in Kidney Transplantation-Reference-Cited by-同舟云学术

Urinary Proteomics in Kidney Transplantation

Published:2021-12-01 Issue:3 Volume:42 Page:7-16
ISSN:1857-8985
Container-title:PRILOZI
language:en
Short-container-title:

Author:

Spasovski Goce¹,Rambabova-Bushljetik Irena¹,Trajceska Lada¹,Dohcev Saso²,Stankov Oliver²,Stavridis Sotir²,Saidi Skender²,Dimitrovski Koco³,Popov Zivko⁴

Affiliation:

1. Department of Nephrology, Medical Faculty , University of Ss. Cyril and Methodius , Skopje , N. Macedonia

2. Department of Urology, Medical Faculty , University of Ss. Cyril and Methodius , Skopje , N. Macedonia

3. Institute for Transfusion Medicine , Skopje , N. Macedonia

4. Macedonian Academy of Sciences and Arts Skopje , N. Macedonia

Abstract

Abstract Although kidney transplantation is the best treatment option for end stage kidney disease, it is still associated with long-term graft failure. One of the greater challenges for transplant professionals is the ability to identify grafts with a high risk of failure before initial decline of eGFR with irreversible graft changes. Transplantation medicine is facing an emerging need for novel disease end point-specific biomarkers, with practical application in preventive screening, early diagnostic, and improved prognostic and therapeutic utility. The aim of our review was to evaluate the clinical application of urinary proteomics in kidney transplant recipients at risk for any type of future graft failure.

Publisher

Walter de Gruyter GmbH

Link

https://www.sciendo.com/pdf/10.2478/prilozi-2021-0030

Reference54 articles.

1. 1. Abecassis M, Bartlett ST, Collins AJ, et al. Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clinical journal of the American Society of Nephrology: CJASN. 2008; 3: 471–480.10.2215/CJN.05021107239094818256371

2. 2. Coemans M, Süsal C, Döhler B, Anglicheau D, Giral M, Bestard O, Legendre C, Emonds MP, Kuypers D, Molenberghs G, Verbeke G, Naesens M (2018). Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015. Kidney Int. 94: 964–973.

3. 3. Bertram L. Kasiske. Proteinuria and Other Urinary Biomarkers in Kidney Transplantation: Why Are We Still Waiting for Godot?2011 Am.J Kidney Dis2011; 57 (5): 654–656.10.1053/j.ajkd.2011.01.00221496726

4. 4. Roodnat J.I.Mulder P.G. Rischen-Vos J.et al. Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation. 2001; 72: 438–444.10.1097/00007890-200108150-0001411502973

5. 5. Jean-Michel Halimi Inass Laouad Matthias Buchler Azmi Al-Najjar Valérie Chatelet Tarik Sqalli Houssaini Hubert Nivet Yvon Lebranchu. Early Low-Grade Proteinuria: Causes, Short-Term Evolution and Long-Term Consequences in Renal Transplantation. Am J Transplant. 2005; 5: 2281–2288.10.1111/j.1600-6143.2005.01020.x16095510

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing kidney transplant outcomes: the role of urinary proteomics in graft function monitoring and rejection detection;Expert Review of Proteomics;2024-08-02

2. Proteomics: Its Promise and Pitfalls in Shaping Precision Medicine in Solid Organ Transplantation;Transplantation;2023-02-20